Hostname: page-component-74656f9884-8r8nv Total loading time: 0 Render date: 2026-11-08T23:22:42.324Z Has data issue: false hasContentIssue false

Social environment as a modulator of immunosenescence

Published online by Cambridge University Press:  01 August 2022

A. Garrido*
Affiliation:
Department of Immunology and Oncology, National Centre for Biotechnology (CNB), Spanish Research Council (CSIC), Madrid, Spain
I. Martínez de Toda
Affiliation:
Department of Genetics, Physiology, and Microbiology (Physiology Unit), School of Biology, Complutense University of Madrid, Madrid, Spain Institute of Investigation of Hospital 12 de Octubre (i+12), Madrid, Spain
E. Díaz del Cerro
Affiliation:
Department of Genetics, Physiology, and Microbiology (Physiology Unit), School of Biology, Complutense University of Madrid, Madrid, Spain Institute of Investigation of Hospital 12 de Octubre (i+12), Madrid, Spain
J. Félix
Affiliation:
Department of Genetics, Physiology, and Microbiology (Physiology Unit), School of Biology, Complutense University of Madrid, Madrid, Spain Institute of Investigation of Hospital 12 de Octubre (i+12), Madrid, Spain
N. Ceprián
Affiliation:
Department of Genetics, Physiology, and Microbiology (Physiology Unit), School of Biology, Complutense University of Madrid, Madrid, Spain Institute of Investigation of Hospital 12 de Octubre (i+12), Madrid, Spain
M. González-Sánchez
Affiliation:
Department of Genetics, Physiology, and Microbiology (Physiology Unit), School of Biology, Complutense University of Madrid, Madrid, Spain Institute of Investigation of Hospital 12 de Octubre (i+12), Madrid, Spain
M. De la Fuente
Affiliation:
Department of Genetics, Physiology, and Microbiology (Physiology Unit), School of Biology, Complutense University of Madrid, Madrid, Spain Institute of Investigation of Hospital 12 de Octubre (i+12), Madrid, Spain
*
Author for correspondence: A. Garrido, E-mail: agarrido@cnb.csic.es
Rights & Permissions [Opens in a new window]

Abstract

Immune system aging, a process known as immunosenescence, involves a striking rearrangement affecting all immune cells, resulting in an increased rate of infections and a major incidence of autoimmune diseases and cancer. Nonetheless, differences in how individuals of the same chronological age carry out this immunosenescence establishment and thus the aging rate have been reported. In the context of neuroimmunoendocrine communication and its role in the response to stress situations, growing evidence suggests that social environments profoundly influence all physiological responses, especially those linked to immunity. Accordingly, negative contexts (loneliness in humans/social isolation in rodents) were associated with immune impairments and decreased lifespan. However, positive social environments have been correlated with adequate immunity and increased lifespan. Therefore, the social context in which an individual lives is proposed as a decisive modulator of the immunosenescence process and, consequently, of the rate of aging. In this review, the most important findings regarding how different social environments (negative and positive) modulate immunosenescence and therefore the aging rate, as well as the role of stress responses, hormesis, and resilience in these environments will be explained. Finally, several possible molecular mechanisms underlying the effects of negative and positive environments on immunosenescence will be suggested.

Information

Type
Review
Copyright
Copyright © The Author(s), 2022. Published by Cambridge University Press
Figure 0

Fig. 1. Dual role of social experiences on health. Depending on the circumstances, social relationships can be a source of stress or a buffer against it. In this regard, negative social interactions, as well as loneliness and social isolation, are associated with the overactivation of the neuroendocrine SAM and HPA axes, releasing CA and GC. If these social-psychological stresses are maintained over time, alterations in all physiological systems are triggered, promoting the acceleration of aging, and increasing the risk of diseases. However, when these social environments are positive such as positive social interactions or positive loneliness (when the individual wants to be alone), they buffer against stress. These positive social experiences as well as low doses and short times of exposure to social threats (perceived as a mild stress situation) can help to develop mechanisms improving the subsequent stress responses and the general function of the organism, process so-called hormesis. Moreover, depending on the individual context (personality, …), the development of hormesis can promote a high resilience capacity, improving all physiological responses and achieving better maintenance of health. CA, catecholamines; GC, glucocorticoids; HPA, Hypothalamic-Pituitary-Adrenal; SAM, Sympathetic-Adreno-Medullary.

Figure 1

Table 1. Overview of the most important findings about effects of social environments on immunosenescence and health

Figure 2

Fig. 2. Effects of positive and negative social environments on immune function. Exposure to positive social environments triggers the release of OXT, which produces the blockage of the neuroendocrine SAM and HPA axes. As a consequence of this blockage and the immunomodulatory capacities of Oxytocin, several immune functions are improved. In fact, leucocytes from individuals exposed to positive social environments exhibit high chemotaxis and phagocytic process, both processes closely linked with innate immunity. Also, the natural killer activity of these individuals is potentiated. With regard to acquired immunity, a high lymphoproliferation in response to stimuli has been also reported. These immune improvements are associated with low oxidative stress and low sterile inflammation establishment. However, if an individual is exposed to negative social environments, the overactivation of both SAM and HPA axes is promoted, triggering the increase of its neuroendocrine mediators, such as catecholamines (epinephrine and norepinephrine) and glucocorticoids (cortisol), respectively. If this psychological stress situation is maintained over time, an impairment in leucocyte functions is triggered. Among them, low chemotaxis, phagocytosis, and natural killer activity together with low stimulated lymphoproliferation appear. Moreover, oxidative and inflammatory stresses are established. Therefore, these negative social environments accelerate the appearance of immunosenescence. HPA, Hypothalamic-Pituitary-Adrenal; SAM, Sympathetic-Adreno-Medullary.

Figure 3

Fig. 3. Several molecular mechanisms of social environment effects. The mechanisms underlying the effects that the social environment has on the organism may depend on the type (positive or negative environments). Thus, on one hand, in individuals exposed to negative environments (loneliness, social isolation, or negative social interactions) the overactivation of neuroendocrine stress axes (HPA and SAM axes) appears, triggering the continuous release of glucocorticoids (GC) and catecholamines (CAs). Indeed, alterations in gene transcription have been reported. Among them, the activation of pro-inflammatory genes which will increase the inflammatory state of the individual is one the most known. Finally, changes in epigenetic mechanisms such as abnormal methylations and reduced acetylations are produced. On the other hand, when an individual is exposed to positive environments, they show an increase in oxytocin (OXT) release, mainly produced by the posterior pituitary. Also, mechanisms generating resistance to changes in gene transcription have been suggested. Similarly, the increase of other neural players, such as opioids, serotonin, and/or dopamine has been described. Finally, a decrease of mitochondrial DNA (mitDNA) insertions into the genomic DNA, a process closely related to immunosenescence, could be occurring in leucocytes from these individuals. BDNF, Brain-Derived Neurotrophic Factor; CA, catecholamines; GC, glucocorticoids; HPA, Hypothalamic-Pituitary-Adrenal; OXT, oxytocin; SAM, Sympathetic-Adreno-Medullary; mitDNA, Mitochondrial DNA.